View all articles

  1. Meeting abstracts

    18th European Symposium on Radiopharmacy and Radiopharmaceuticals

    V. Radchenko, J. W. Engle, C. Roy, J. Griswold, M. F. Nortier, E. R. Birnbaum, M. Brugh, S. Mirzadeh, K. D. John, M. E. Fassbender, Chuangyan Zhai, Gerben M. Franssen, Milos Petrik, Peter Laverman, Clemens Decristoforo, Ait-Mohand Samia…

    Published on: 17 June 2016

View all articles

Check if your institution is a member

More than 500 institutions have partnered with SpringerOpen through the membership program. As an affiliated Author from a member institution, you may be entitled to submit your manuscript without paying the article processing charge (APC) or with a discount. Check here if your institution is a member!

EANM sponsorship programme

The EANM Board decided to allocate funds to a dedicated Publication Fee Sponsorship Programme for the entire EJNMMI journal family. Through this programme the EANM will cover the charges that arise for selected open choice publications in the EJNMMI and open access publications in EJNMMI Research, EJNMMI Physics, EJNMMI Radiopharmacy and Chemistry as well as the European Journal of Hybrid Imaging.

Read more

Aims and scope

EJNMMI Radiopharmacy and Chemistry publishes new research in the field of development of new imaging and radionuclide based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight in novel concepts of imaging or radionuclide based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in from of guidelines or position papers.

Need help with APC funding?

New Content Item

We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. 

Learn more here​​​​​​​

Meet the Editor in Chief at ESRR'18!

Are you attending the 19th European Symposium on Radiopharmaceuticals in Groningen this year?

Meet up with our Editor in Chief, Philip Elsinga, to chat about latest developments in the field, the journal EJNMMI Radiopharmacy and Chemistry and open access publishing!

Interested? Please contact Philip here.


Upcoming events

EANM 2018

Neuer Inhalt

Related websites

Searching for an article? Easily browse the EJNMMI journals on the Nuclear Medicine and Molecular Imaging webportal.